Cargando…
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Metabolic reprogramming is a feature of cancers for which recent research has been particularly active, providing numerous insights into the mechanisms involved. It occurs across the entire cancer process, from development to resistance to therapies. Established tumors exhibit dependencies for metab...
Autores principales: | Reyes-Castellanos, Gabriela, Abdel Hadi, Nadine, Carrier, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834004/ https://www.ncbi.nlm.nih.gov/pubmed/35159234 http://dx.doi.org/10.3390/cells11030426 |
Ejemplares similares
-
Targeting Redox Metabolism in Pancreatic Cancer
por: Abdel Hadi, Nadine, et al.
Publicado: (2021) -
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2020) -
The Metabolism Reprogramming of microRNA Let-7-Mediated Glycolysis Contributes to Autophagy and Tumor Progression
por: Li, Chien-Hsiu, et al.
Publicado: (2021) -
Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019) -
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)